New pharma industry exhibition and conference will take place May 16–18, 2017 in Philadelphia, PA.
CPhI, organizer of pharmaceutical business and networking events in Europe, China, Japan, Southeast Asia, India, Russia, and Istanbul, announced on April 13, 2016 that it will be hosting the first CPhI North America conference, from May 16–18, 2017 at the Pennsylvania Convention Center in Philadelphia, PA. The event is positioned to connect buyers and sellers across the pharmaceutical supply chain, pharmaceutical ingredients, contract services, packaging, machinery, technology, finished dosage formulations, and bio services in the North American market, CPhI reports.
CPhI North America will offer networking and educational opportunities, including an onsite conference program hosted in partnership with CBI, a life-science conference producer. The event will focus on the buying and selling of pharmaceutical ingredients and APIs, contract services, packaging, machinery/technology, finished dosage formulation, and biopharmaceuticals.
CPhI North America will be co-located with InformEx, a chemistry innovation event. The following brands, affiliated with CPhI Worldwide, will comprise the zoned show floor:
CPhI North America team will be hosting a preview event for prospective exhibitors and interested media on May 25, 2016 at the Pennsylvania Convention Center.
CPhI, CBI, and Pharmaceutical Technology are UBM plc brands.
Source: CPhI
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.